CLINICAL_TRIALS
trial_result
· 2007-08-29
Clinical Trial Update: RBx11160 Phase II Dose Ranging Study RBx/MMV05-06 [Phase 2]
Summary
Medicines for Malaria Venture reports that the Phase II dose-ranging study RBx/MMV05-06 evaluating RBx11160 has completed. The trial investigated RBx11160 for P…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Medicines for Malaria Venture | Conditions: Plasmodium Falciparum Malaria | Phase 2 | Status: COMPLETED